CardioLab ApS: Financial statements 2025
CVR: 38276409
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
CardioLab ApS (CVR 38276409) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 220,391 and a net result of DKK 141,107 compared with DKK 814,756 the year before. That is a decrease of 90.4% compared with the year before. Equity in the 2025 report amounted to DKK 1,544,977. The solvency ratio was 66.5%.
- Gross Profit
- DKK 220,391
- Profit/Loss
- DKK 141,107
- Equity
- DKK 1,544,977
- Total Assets
- DKK 2,323,254
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 220 t. | 141 t. | 1.5 mio. | 0 |
| 2024 | - | 2.3 mio. | 815 t. | 1.4 mio. | 4 |
| 2023 | - | 750 t. | -58 t. | 589 t. | 4 |
| 2022 | - | 1.6 mio. | 137 t. | 647 t. | 5 |
| 2021 | - | 1.1 mio. | 351 t. | 510 t. | 3 |
Official annual report
How creditworthy is CardioLab ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
CardioLab ApS has published its annual report for 2024. Gross profit came to DKK 2,286,023, and the net result was DKK 814,756.
About CardioLab ApS
CardioLab ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2016. The company is registered under the industry Speciallægers aktiviteter. The management consists of Janet Alsø and Susan Alsø. The company is owned by New Cardiolab ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 220,391 and a net result of DKK 141,107 compared with DKK 814,756 the year before. Equity in the 2025 report amounted to DKK 1,544,977.